Kitea Health and SCHOTT Primoceler Oy collaborate on miniaturised sensor implant technology
The system empowers individuals to manage their health proactively, reducing the burden on healthcare systems and improving overall outcomes (Image: Kitea Health)
The development of the sensor implant is the culmination of 15 years of research by the Implantable Device Group at the Auckland Bioengineering Institute, University of Auckland, as well as recent collaboration with SCHOTT Primoceler Oy.
Register for FREE to keep reading
Join 15,000+ photonics professionals staying ahead with:
- Exclusive insights, funding alerts & market trends
- Curated newsletters and digital editions
- Access to The Photonics100 list of R&D champions
- Exclusive panels & roundtables for professional development
- Technical White Papers & product updates to guide smarter decisions
Sign up now
Already a member? Log in here
Your data is protected under our privacy policy.
